Evidence map›Paper›PMID 35527489›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[Therapeutic effect of

Q Zou, X Wu, J Wang, D Xia, M Deng, Y Ding, Y Dai, S Zhao, T Chen

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Animals : an open access journal from MDPI · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Q ZouSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
X WuSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
J WangSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
D XiaSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
M DengSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Y DingSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Y DaiSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
S ZhaoYunnan Food and Drug Inspection Center, Kunming 650228, China.
T ChenSchool of Pharmaceutical Science and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Kunming Medical University · CNShandong Institute of Food and Drug Inspection · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the therapeutic effects of total saponins from

methodsWe examined the effects of treatment with different concentrations of PNS on H

resultsTreatment with PNS concentration-dependently inhibited the proliferation and significantly promoted apoptosis of cultured H

conclusionPNS alone or in combination with CTX can improve the immunity and tumor inhibition rate and prolong the survival time of H

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsPanax notoginsengSaponinsAnimalsCyclophosphamideHemolysin ProteinsHeterograftsHumansInterleukin-2MiceTumor Necrosis Factor-alphaCyclophosphamideHemolysin ProteinsInterleukin-2SaponinsTumor Necrosis Factor-alphaanti-tumor rateH22 cellsimmunityliver cancerPanax notoginseng total saponinssurvival time

Identifiers

PMID35527489
PMCPMC9085587
OpenAlexW4229451655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.